With a focus on advancing and commercializing therapies for autoimmune diseases and cancer, we strive to use evidence-based medicine to increase the longevity and quality of people’s lives. We have developed a novel methotrexate drug delivery system that has the potential to improve tolerability, increase bioavailability, and enable patients to manage their own therapy. Learn more about this treatment in our product portfolio.